Patent Yard Sign in
Canadian application, no grantCanada

A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity

CA 2460629 A1 · Owner: Havranova, Marie · Inventors: Havranova, Marie

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for the measurement of the activation of the basophils following stimulation with an allergen to determine hypersensitivity to some substances in which a blood sample with an addition of interleukin-3 in a quantity of 0.05 to 50 ng/ml, based on the volume of the sample and of appropriately , diluted allergen in a quantity of 0.5 to 100 units/ml is incubated at the temperature corresponding to the physiological environment for 15 to 45 minutes, whereafter a staining with anti-CD63 antibody in an amount of 3 to 30 ~l/1OO ~l of blood and with the antibody against a surface receptor of the basophil in an amount of 3 to 30 ~l/1OO ~l of blood are added at a temperature of 0 to +10 …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 10, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 10, 2002
GrantedNo grant recorded
Term endedSeptember 10, 2022
Patent numberCA 2460629 A1
Classification (IPC)G01N33/56

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedSep 10, 2002Term endedSep 10, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.